Spectrum Medical

What Spectrum Medical does

Spectrum Medical (杭州谱聚医疗科技有限公司) is a Hangzhou-based clinical mass spectrometry product platform founded in 2020, though its core R&D team traces back to 2006 and was awarded a National Major Scientific Instrument Development Project grant in 2011. The company develops and manufactures a full line of clinical mass spectrometry instruments under the PreMed brand — LC-MS/MS systems (PreMed 5200, 5300, 5600, PreMed 5000 series), ICP-MS systems (PreMed 7000, 7200), ICP-MS/MS systems (PreMed 7350), GC-MS/MS systems (PreMed 6000), MALDI-TOF Gene TOF systems (PreMed 1000), and automated sample preparation systems (PreMed 3500, 3300). It also offers clinical reagent kits for vitamin, trace element, hormone, amino acid, fatty acid, bile acid, and therapeutic drug monitoring panels. Spectrum Medical claims to be the only company in China with proprietary triple quadrupole mass spectrometry intellectual property and to achieve over 90% domestic component sourcing across its instruments, directly addressing historical Chinese dependence on imported clinical mass spectrometry systems.

The company monetizes through three primary revenue streams: (1) hardware sales of PreMed instruments and sample preparation systems to hospitals, clinical laboratories, and research institutions; (2) recurring revenue from registered and filed clinical reagent kits covering vitamins, trace elements, drug monitoring, and metabolic panels; and (3) professional services including third-party outsourced clinical mass spectrometry testing, laboratory co-construction partnerships with hospitals, and laboratory developed test (LDT) method development. Distribution is sales-led, with direct representatives targeting healthcare providers and on-site service teams providing installation, training, and maintenance. Customer segmentation spans four verticals: hospital clinical laboratories (vitamins, trace elements, hormones, metabolic markers), healthcare and wellness institutions (precision nutrition, chronic disease screening), maternal and child health institutions (newborn genetic metabolic disease screening), and pharmaceutical and research institutions (therapeutic drug monitoring, PK studies).

Spectrum Medical is privately held, headquartered in Hangzhou's Binjiang District with an additional service site in Lin'an District, and currently employs 51–100 people. The company closed a 185 million RMB Series B round led by Sequoia China in June 2022, holds 20+ core patents, operates a 5000+ m² production base with cumulative 1000+ PreMed 7000 ICP-MS shipments, has 30+ approved reagent kits, and has secured ISO 13485 (November 2022), ISO 9001 (June 2022), and National High-Tech Enterprise (January 2024) recognitions. Operations remain domestic-focused across China with no disclosed international footprint.

Name

Spectrum Medical

Legal name

杭州谱聚医疗科技有限公司

Website

https://expeclin.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Spectrum Medical is a Hangzhou-based clinical mass spectrometry platform founded in 2020 that develops LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF instruments under the PreMed brand, serving Chinese hospitals, maternal-child health centers, wellness institutions, and pharmaceutical researchers.

Ownership category

akta.pro rank

Product category

Clinical Mass Spectrometry Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)

SIC

Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)

akta.pro secondary industries

Proteomics & Mass Spectrometry Services (HLAGANAB), Analytical Instruments & Chromatography Systems (HLAGAIAA)

Keywords

• Clinical mass spectrometry
• LC-MS/MS instruments
• ICP-MS systems
• Medical reagent kits
• Clinical diagnostic equipment

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Mass Spectrometry Equipment Sales: Sale of clinical mass spectrometry instruments including LC-MS/MS, ICP-MS, GC-MS/MS, and Gene TOF systems along with automated sample preparation systems. Equipment is sold directly to hospitals, clinical laboratories, and research institutions.
2. Reagent Kits and Consumables: Sale of clinical mass spectrometry detection reagent kits for vitamins, trace elements, drug monitoring, amino acids, fatty acids, and bile acid profiles. Both registered and filed reagent kits available.
3. Third-Party Medical Testing Services: Outsourced clinical mass spectrometry testing services, clinical mass spectrometry laboratory co-construction, and LDT (Laboratory Developed Test) method development services.
4. Laboratory Construction and Support Services: Laboratory planning, instrument selection, equipment maintenance, personnel training system construction, and standardized service processes for clinical mass spectrometry labs.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Spectrum Medical (杭州谱聚医疗科技有限公司) develops, manufactures, and sells clinical mass spectrometry instrument platforms — LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF (Gene TOF) systems — together with proprietary in-vitro diagnostic reagent kits and automated sample-preparation workstations. Beyond instruments and consumables, the company operates third-party clinical mass-spec testing services and laboratory co-construction programs for hospitals and medical institutions.

Product overview

谱聚医疗 (Spectrum Medical/PuJu Medical) offers a comprehensive clinical mass spectrometry product portfolio including LC-MS/MS systems (PreMed 5200, PreMed 5600, PreMed 5000 series), ICP-MS systems (PreMed 7000, PreMed 7200), ICP-MS/MS systems (PreMed 7350), GC-MS/MS systems (PreMed 6000), MALDI-TOF systems (PreMed 1000), and automated sample pretreatment systems (PreMed 3500, PreMed 3300). The product line also includes clinical reagent kits for vitamin detection, drug concentration monitoring, amino acid profiles, fatty acid profiles, bile acid profiles, and genetic metabolic disease screening. The company is the only domestic enterprise in China with proprietary intellectual property for triple quadrupole technology, achieving over 90% domestic component localization.

Differentiator

Problem solved

Functional benefit

Brands

• PreMed: 临床质谱设备品牌，包括PreMed 5200、5600、7000、6000、1000、3300、3500等多种型号，覆盖LC-MS/MS、ICP-MS、GC-MS/MS、Gene TOF等质谱平台及全自动样本前处理系统

Products and services

• PreMed 5200 LC-MS/MS Clinical liquid chromatography–tandem mass spectrometry instrument for quantitative in-vitro diagnostic testing in hospital and clinical laboratories.
• PreMed 5600 LC-MS/MS Higher-throughput clinical LC-MS/MS instrument for quantitative in-vitro diagnostic assays such as therapeutic-drug monitoring and hormone profiling.
• PreMed 5000 Series LC-MS/MS Family of clinical LC-MS/MS instruments for routine quantitative in-vitro diagnostic testing in clinical laboratories.
• PreMed 7000 ICP-MS Clinical inductively coupled plasma mass spectrometry instrument for trace-element analysis in clinical samples.
• PreMed 7200 ICP-MS Clinical ICP-MS instrument for quantitative trace-element and metal analysis in clinical diagnostic workflows.
• PreMed 7350 ICP-MS/MS Triple-quadrupole ICP-MS/MS clinical instrument for high-sensitivity trace-element analysis with reduced spectral interference in clinical diagnostics.
• PreMed 6000 GC-MS/MS Clinical gas chromatography–tandem mass spectrometry instrument for volatile and small-molecule clinical assays.
• PreMed 1000 Gene TOF (MALDI-TOF) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for clinical microbial identification in hospital microbiology laboratories.
• PreMed 3500 Automated Sample Preparation System Automated clinical sample-preparation workstation used upstream of LC-MS/MS and ICP-MS systems to standardize sample handling.
• PreMed 3300 Automated Sample Preparation System Automated sample-preparation workstation for clinical mass-spectrometry workflows.
• Clinical IVD Reagent Kits Proprietary in-vitro diagnostic reagent kits for use on Spectrum Medical's mass spectrometry platforms, covering therapeutic drugs, vitamins (including vitamin D), steroid hormones, and trace elements.
• Third-Party Clinical Mass Spectrometry Testing Services Centralized third-party clinical mass spectrometry testing services offered to hospitals, clinics, and other medical institutions that do not run mass-spec assays in-house.
• Laboratory Co-Construction (Lab Co-Build) Services Partnership program in which Spectrum Medical co-builds and operates clinical mass spectrometry laboratories inside hospitals or healthcare networks, providing instruments, reagents, workflow, and staff training.

Quantifiable outcome

• PreMed 5600 signal intensity improved 10x with 2-8x SNR improvement over PreMed 5200
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Chengdu Tianfu International Bio-citycoreStrategic or Co-development Partner · 14 June 2023Spectrum Medical participated as a strategic partner in the 'Innovation Shapes the Future' Chengdu Tianfu International Bio-city Innovation Ecosystem Forum, engaging with bio-pharmaceutical experts and scholars on industry ecosystem development.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• SCIEX (Danaher): SCIEX, a Danaher operating company, is a global leader in mass spectrometry with a deeply entrenched clinical LC-MS/MS installed base; the closest global incumbent peer to Spectrum Medical's PreMed LC-MS/MS and triple-quadrupole systems.
• Agilent Technologies: Agilent is a global analytical instrument leader with strong LC-MS/MS, GC-MS/MS, and ICP-MS product lines competing for the same hospital and clinical laboratory customers as Spectrum Medical.
• Waters Corporation: Waters is a global mass spectrometry leader with deep penetration in clinical and biomedical research laboratories, offering LC-MS/MS and ion-mobility systems directly comparable to Spectrum Medical's PreMed platform.
• Shimadzu: Shimadzu offers a broad mass spectrometry portfolio (LC-MS/MS, GC-MS/MS, ICP-MS) widely deployed across Asian clinical laboratories, making it a direct competitor to Spectrum Medical's PreMed series in the Chinese market.
• Thermo Fisher Scientific: Thermo Fisher operates one of the world's largest analytical instrument businesses including clinical mass spectrometry; its scale, service network, and reagent ecosystem are a structural benchmark for Spectrum Medical's ambitions.
• Bruker: Bruker is a global mass spectrometry and MALDI-TOF leader; its clinical microbiology and nucleic-acid mass spec systems overlap with Spectrum Medical's PreMed 1000 Gene TOF platform.
• Mindray Medical (迈瑞医疗): Mindray is China's largest domestic medical device company with a broad IVD portfolio; while not primarily a mass spectrometry vendor, it is a potential adjacent competitor as it expands into higher-end clinical diagnostics in Chinese hospitals.

Direct peers

• Calibra Diagnostics (凯莱谱): Calibra Diagnostics is a Chinese clinical mass spectrometry startup that builds LC-MS/MS platforms and IVD reagent kits for therapeutic drug monitoring — directly competing with Spectrum Medical in the same Chinese clinical mass spec niche.
• Dian Diagnostics (迪安诊断): Dian Diagnostics operates one of China's largest independent medical laboratory networks; its third-party clinical testing and lab-co-construction services directly compete with Spectrum Medical's testing and lab-services revenue streams.

Regional players

• Autobio Diagnostics (安图生物): Autobio is a leading Chinese IVD and immunoassay company that serves similar hospital clinical laboratory customers and could expand into the clinical mass spectrometry segment Spectrum Medical targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spectrum Medical